Clinical Trials Browser

Neoplastic Cells, Circulating × Blood Specimen Collection × Genitourinary × Clear all

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT05437679 2023-09-05

CHARTER

Terminated

9 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03381326 2023-06-02

IRSTB030

Unknown

104 enrolled

Genitourinary

Neoplastic Cells, Circulating, Neoplasm Metastasis, Prostatic Neoplasms

NCT04280640 2021-10-18

Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes

Withdrawn

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Gastrointestinal Neoplasms, Neoplastic Cells, Circulating, Neoplasms

NCT02742259 2019-03-26

VPCA-B+PIV

Withdrawn

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT02940977 2018-07-10

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Unknown

120 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Hyperplasia, Prostatic Neoplasms

NCT01528774 2017-07-26

CTC

Completed

150 enrolled

DermatologicGenitourinarySarcoma

Kidney Neoplasms, Melanoma, Neoplastic Cells, Circulating, Prostatic Neoplasms, Sarcoma, Somatostatinoma

NCT02345473 2015-01-26

CirCanCell

Completed

59 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplastic Cells, Circulating

Clinical Trials

EPIDROP

CHARTER

IRSTB030

Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes

VPCA-B+PIV

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

CTC

CirCanCell